Serafini, A N <br/><br/>
Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  May 1998 
 - 1777-87 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1998.16.5.1777  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--adverse effects<br/>Colorectal Neoplasms--diagnostic imaging<br/>Humans<br/>Middle Aged<br/>Neoplasm Metastasis--diagnostic imaging<br/>Neoplasm Recurrence, Local--diagnostic imaging<br/>Radioimmunodetection<br/>Sensitivity and Specificity<br/>Technetium--adverse effects<br/>Tomography, Emission-Computed, Single-Photon<br/>Tomography, X-Ray Computed